Evonik, a leading specialty chemical company, and BellaSeno, a medical company focused on regenerative implants, have announced their joint efforts in advancing the commercialization of 3D-printed bioresorbable implants for bone regeneration. The two companies first joined forces in 2019 to work on scaffolds designed for chest wall and breast reconstruction.
BellaSeno’s custom-made, 3D-printed tissue scaffolds are a breakthrough in the treatment of bone and soft tissue defects. By ensuring the correct anatomical positions of tissue grafts, they offer a significant improvement over tissue autographs, which can lack stability and cannot be packed in a controlled manner.
The scaffolds are made from Resomer, which is a comprehensive portfolio of bioresorbable polymers for use with medical implants. Resomer offers various formulations for 3D printing, including filaments and powders that enable customized solutions for a diverse range of applications. The 3D-printed implants offer a more personalized solution for patients, improving both the functional and aesthetic outcomes of the surgery. The bioresorbable nature of the implants also reduces the risk of complications and reduces the need for additional surgeries.
Commercial availability of these implants would represent a significant advancement in medical technology, providing new opportunities for personalized care.